Literature DB >> 3009521

Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.

B M Arafah.   

Abstract

Detailed pituitary function studies were conducted on 26 patients with large nonfunctioning pituitary adenomas before and 2-3 months after transsphenoidal adenomectomy. Basal serum PRL, GH, TSH, LH, FSH, and ACTH levels were measured, and dynamic studies of their secretion were made. Preoperatively, GH deficiency was found in all 26 patients (100%), hypogonadism in 25 patients (96%), hypothyroidism in 21 patients (81%), and adrenal insufficiency in 16 patients (62%). Serum PRL levels were low (1.5-4 ng/ml) in 5 patients, normal (5-20 ng/ml) in 9 patients, and mildly elevated (21-53 ng/ml) in the remaining 12 patients. After selective adenomectomy, variable improvement in pituitary function occurred in 17 patients, worsening in 1 patient, and persistence of hypopituitarism in 8 patients. After surgery, normal thyroid function was documented in 12 of the 21 patients (57%) who were hypothyroid preoperatively. Similarly, 6 of the 16 patients (38%) with adrenal insufficiency recovered normal adrenal function, and 8 of the 25 patients (32%) with hypogonadism recovered normal gonadal function. GH deficiency persisted in all but 4 patients (15%). Serum PRL levels decreased in all patients, and only 5 had midly elevated levels after surgery. The presence of a normal or mildly elevated serum PRL level before surgery in these patients was of value in predicting possible recovery of pituitary function after surgery; none of the 5 patients with low preoperative serum PRL levels had any improvement in pituitary function after surgery. A rise in serum TSH levels after TRH administration before surgery also was helpful in predicting possible recovery from hypopituitarism. Most patients who had a rise in serum TSH level in response to TRH stimulation preoperatively recovered some pituitary function after adenomectomy. In contrast, no improvement in pituitary function occurred in patients who had blunted responses to TRH preoperatively. Improvement in pituitary function occurred more often in patients with tumors measuring 25 mm or less than in those with larger tumors. In conclusion, significant improvement in pituitary function may occur after surgical adenomectomy for nonsecreting pituitary tumors. A rise in serum TSH levels in response to TRH stimulation preoperatively suggested the presence of viable pituitary tissue in these patients with hypopituitarism. The presence of a normal or mildly elevated serum PRL level before surgery also suggested the presence of functioning pituitary lactotrophs. These observations suggest that compression of the portal circulation is a possible mechanism for hypopituitarism in this setting.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009521     DOI: 10.1210/jcem-62-6-1173

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

Review 1.  Neurology of the pituitary gland.

Authors:  J R Anderson; N Antoun; N Burnet; K Chatterjee; O Edwards; J D Pickard; N Sarkies
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

2.  Evaluation of pituitary macroadenomas with multidetector-row CT (MDCT): comparison with MR imaging.

Authors:  Yukio Miki; Mitsunori Kanagaki; Jun A Takahashi; Koichi Ishizu; Masayuki Nakagawa; Akira Yamamoto; Yasutaka Fushimi; Tsutomu Okada; Nobuhiro Mikuni; Ken-ichiro Kikuta; Nobuo Hashimoto; Kaori Togashi
Journal:  Neuroradiology       Date:  2007-01-03       Impact factor: 2.804

3.  Pituitary apoplexy in an adrenocorticotropin-producing pituitary macroadenoma.

Authors:  Serap Baydur Sahin; S Cetinkalp; M Erdogan; U Cavdar; G Duygulu; F Saygili; C Yilmaz; A G Ozgen
Journal:  Endocrine       Date:  2010-07-14       Impact factor: 3.633

4.  Experience in management of 51 non-functioning pituitary adenomas: indications for post-operative radiotherapy.

Authors:  C Alameda; T Lucas; E Pineda; M Brito; J G Uría; R Magallón; J Estrada; B Barceló
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

5.  Outcome of pituitary hormone deficits after surgical treatment of nonfunctioning pituitary macroadenomas.

Authors:  Orsalia Alexopoulou; Valérie Everard; Martine Etoa; Edward Fomekong; Stéphane Gaillard; Fabrice Parker; Christian Raftopoulos; Philippe Chanson; Dominique Maiter
Journal:  Endocrine       Date:  2021-04-14       Impact factor: 3.633

Review 6.  Guidelines in the management of CNS tumors.

Authors:  Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

Review 7.  Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose; Salvatore Benvenga
Journal:  Endocrine       Date:  2018-09-06       Impact factor: 3.633

Review 8.  Medical management of hypopituitarism in patients with pituitary adenomas.

Authors:  Baha M Arafah
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

9.  Dopamine agonist therapy induces significant recovery of HPA axis function in prolactinomas independent of tumor size: a large single center experience.

Authors:  Christine G Yedinak; Isabelle Cetas; Alp Ozpinar; Shirley McCartney; Aclan Dogan; Maria Fleseriu
Journal:  Endocrine       Date:  2016-07-26       Impact factor: 3.633

10.  The pituitary stalk effect: is it a passing phenomenon?

Authors:  Marvin Bergsneider; Leili Mirsadraei; William H Yong; Noriko Salamon; Michael Linetsky; Marilene B Wang; David L McArthur; Anthony P Heaney
Journal:  J Neurooncol       Date:  2014-02-19       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.